Reference:
Front Line COVID-19 Critical Care Alliance. (2021). Prevention & treatment protocols for COVID-19: Management protocol for Long Haul COVID-19 Syndrome (LHCS). Retrieved from https://flccc.net/flccc-protocols-a-guide-to-the-management-of-covid-19
Summary:
The Front Line COVID-19 Critical Care Alliance (FLCCC) has developed a consensus protocol for managing Long Haul COVID-19 Syndrome (LHCS), which presents a range of symptoms including fatigue, cognitive dysfunction, and respiratory issues lasting months post-infection. The I-RECOVER protocol, led by a team of medical professionals, draws on clinical experiences rather than standard clinical trials, suggesting treatments based on the pathophysiology of COVID-19. Key recommendations include the use of ivermectin for neurological symptoms, corticosteroids for unresolved respiratory issues, and various antihistamines for mast cell activation syndrome. Each treatment is tailored to individual symptoms, with ongoing adjustments as more data emerges. The protocol highlights the importance of early intervention to potentially mitigate the severity of LHCS and emphasises the heterogeneity of this syndrome, which affects a broad demographic, including younger individuals with mild initial COVID-19 cases. The FLCCC Alliance encourages continuous updates to the protocol as further research becomes available, advocating for an informed approach to treatment.